Li S, Wang X, Zhang J, Li J, Liu X, Ma Y, et al
I started this drug three months ago
It may also be recommended for individuals with a BMI of 27 or higher if they have weight-related medical conditions such as hypertension, high cholesterol, or type 2 diabetes
FDA Telehealth Warning Letters In early March 2026, the FDA reportedly issued warning letters to multiple telehealth companies regarding compounded GLP-1 marketing practices, with concerns including misleading marketing claims, implications of equivalence with FDA-approved drugs, and obscuring product sourcing
When glucose is unstable, cravings spike and weight returns after medication stops
So far, research hasnt shown panic attacks to be a direct or common effect of semaglutide, but a small number of people have reported them